In this latest insight our in-house procurement experts offer a snapshot of four recent procurement cases and note valuable lessons for contracting authorities and bidders.

Our team of housing specialists summarises the latest cases and court decisions in one practical update, so you can devote more time to supporting your tenants.

The latest update from NHS England suggests that the NHS Provider Selection Regime may come into force at some point in 2023. We reflect on what this means for healthcare service contracts that will need awarding prior to the new regime coming into force.

It has been confirmed that for cases issued on or after 6 April 2023, a defendant will be able to enforce costs up to “the aggregate amount in money terms of any orders for or agreements to pay or settle a claim for, damages, costs and interest”.

We outline when and why do GP practices need to update their partnership documents, and top tips on how this can be achieved efficiently.

Our Health and Justice insights focuses on the latest legal updates, statistics and good news stories across the health and justice space, complete with commentary from our specialist in-house team.

FRCs in money claims (except clinical negligence) will not be implemented until October 2023 – a second extension of six months on the original timetable.

Module 3 of the public inquiry has a healthcare focus and includes use of the private sector during the pandemic. A virtual and streamed preliminary hearing is scheduled for 28 February 2023.

The private sector is using technology to assist the NHS with post-Covid-19 waiting lists and wider resource issues.

The government plans to introduce a Transport Bill this year which is likely to propose legislation to allow the use of private e-scooters on public roads (currently illegal).

Defendants may soon be able to enforce their costs against a claimant’s costs or damages obtained pursuant to a settlement.

The government’s response to the Medicines and Healthcare Regulatory Authority’s 2022 consultation on the future shape of clinical trials is awaited.